(HWKN) Hawkins - Overview

Sector: Basic Materials | Industry: Specialty Chemicals | Exchange: NASDAQ (USA) | Market Cap: 3.237m USD | Total Return: 21.5% in 12m

Water Chemicals, Industrial Acids, Nutritional Ingredients, Food Blends

Total Rating 57

Safety 91

Buy Signal 0.01

Specialty Chemicals
Industry Rotation: -2.6

Market Cap: 3.24B
Avg Turnover: 22.0M

Risk 3d forecast

Volatility38.1%

VaR 5^th Pctl6.17%

VaR vs Median-1.61%

Reward TTM

Sharpe Ratio0.59

Rel. Str. IBD49.2

Rel. Str. Peer Group13.9

Character TTM

Beta0.485

Beta Downside0.178

Hurst Exponent0.569

Drawdowns 3y

Max DD34.79%

CAGR/Max DD1.48

CAGR/Mean DD5.59

EPS (Earnings per Share)

EPS CAGR: 9.85%
EPS Trend: 84.3%

Last SUE: 0.24
Qual. Beats: 0

Revenue

Rev. CAGR: 6.11%
Rev. Trend: 89.2%

Last SUE: 1.09
Qual. Beats: 1

Warnings

Choppy Below Avwap Earnings

Tailwinds

Shakeout, Confidence

Description: HWKN Hawkins

Hawkins, Inc. (HWKN) is a diversified chemical distributor and manufacturer operating across three primary segments: Water Treatment, Industrial, and Health and Nutrition. Founded in 1938, the company maintains a vertically integrated model that combines large-scale chemical distribution with value-added custom blending and manufacturing services.

The Water Treatment division provides essential chemicals and equipment for municipal and industrial water systems, while the Industrial segment serves a broad range of sectors including energy, pharmaceuticals, and food processing. The Health and Nutrition segment focuses on the distribution and formulation of specialty ingredients like vitamins, minerals, and botanicals for the wellness industry. The specialty chemical distribution sector often benefits from high customer switching costs due to the complex regulatory and safety requirements associated with chemical handling and logistics.

Investors looking for deeper financial metrics should evaluate these segments on ValueRay to identify long-term growth trends.

Headquartered in Minnesota, the company’s business model relies on a regional hub-and-spoke distribution network that minimizes transportation costs for heavy liquid chemicals. This localized infrastructure provides a competitive moat against larger national distributors by ensuring faster delivery times and technical support for municipal contracts.

Headlines to Watch Out For

Strategic acquisitions in fragmented water treatment markets drive sustained revenue growth
Municipal water infrastructure spending levels dictate demand for treatment chemical services
Raw material cost volatility impacts margins across industrial and specialty segments
Consumer demand for functional food and supplements fuels health and nutrition sales
Regulatory compliance costs for chemical storage and distribution affect operating expenses

Piotroski VR-10 (Strict) 6.5

Net Income: 81.5m TTM > 0 and > 6% of Revenue
FCF/TA: 0.09 > 0.02 and ΔFCF/TA -0.50 > 1.0
NWC/Revenue: 11.68% < 20% (prev 12.68%; Δ -1.00% < -1%)
CFO/TA 0.14 > 3% & CFO 144.3m > Net Income 81.5m
Net Debt (275.0m) to EBITDA (167.7m): 1.64 < 3
Current Ratio: 2.21 > 1.5 & < 3
Outstanding Shares: last quarter (20.9m) vs 12m ago 0.11% < -2%
Gross Margin: 22.61% > 18% (prev 0.23%; Δ 2.24k% > 0.5%)
Asset Turnover: 122.3% > 50% (prev 126.6%; Δ -4.23% > 0%)
Interest Coverage Ratio: 8.52 > 6 (EBITDA TTM 167.7m / Interest Expense TTM 13.5m)

Altman Z'' 4.46

A: 0.13 (Total Current Assets 231.5m - Total Current Liabilities 104.8m) / Total Assets 1.00b
B: 0.50 (Retained Earnings 500.1m / Total Assets 1.00b)
C: 0.13 (EBIT TTM 115.1m / Avg Total Assets 885.8m)
D: 1.07 (Book Value of Equity 501.3m / Total Liabilities 467.7m)
Altman-Z'' = 4.46 = AA

Beneish M -2.91

DSRI: 0.94 (Receivables 140.7m/134.7m, Revenue 1.08b/974.4m)
GMI: 1.01 (GM 22.61% / 22.78%)
AQI: 1.25 (AQ_t 0.49 / AQ_t-1 0.39)
SGI: 1.11 (Revenue 1.08b / 974.4m)
TATA: -0.06 (NI 81.5m - CFO 144.3m) / TA 1.00b)
Beneish M = -2.91 (Cap -4..+1) = A

What is the price of HWKN shares?

As of May 24, 2026, the stock is trading at USD 152.63 with a total of 181,055 shares traded.
Over the past week, the price has changed by -3.67%, over one month by -6.50%, over three months by +6.32% and over the past year by +21.54%.

Is HWKN a buy, sell or hold?

Hawkins has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy HWKN.

StrongBuy: 0
Buy: 2
Hold: 0
Sell: 0
StrongSell: 0

What are the forecasts/targets for the HWKN price?

Analysts Target Price	189.3	24%

Hawkins (HWKN) - Fundamental Data Overview as of 22 May 2026

P/E Trailing = 39.0705
P/E Forward = 33.67
P/S = 2.9869
P/B = 5.97
P/EG = 2.8097
Revenue TTM = 1.08b USD
EBIT TTM = 115.1m USD
EBITDA TTM = 167.7m USD
Long Term Debt = 244.0m USD (from longTermDebt, last quarter)
Short Term Debt = 3.00m USD (from shortTermDebt, last quarter)
Debt = 278.9m USD (from shortLongTermDebtTotal, last quarter) + Leases 17.5m
Net Debt = 275.0m USD (calculated: Debt 278.9m - CCE 3.91m)
Enterprise Value = 3.51b USD (3.24b + Debt 278.9m - CCE 3.91m)
Interest Coverage Ratio = 8.52 (Ebit TTM 115.1m / Interest Expense TTM 13.5m)
EV/FCF = 40.79x (Enterprise Value 3.51b / FCF TTM 86.1m)
FCF Yield = 2.45% (FCF TTM 86.1m / Enterprise Value 3.51b)
FCF Margin = 7.94% (FCF TTM 86.1m / Revenue TTM 1.08b)
Net Margin = 7.52% (Net Income TTM 81.5m / Revenue TTM 1.08b)
Gross Margin = 22.61% ((Revenue TTM 1.08b - Cost of Revenue TTM 838.6m) / Revenue TTM)
Gross Margin QoQ = 20.40% (prev 20.82%)
Tobins Q-Ratio = 3.51 (Enterprise Value 3.51b / Total Assets 1.00b)
Interest Expense / Debt = 4.84% (Interest Expense 13.5m / Debt 278.9m)
Taxrate = 22.39% (4.46m / 19.9m)
NOPAT = 89.3m (EBIT 115.1m * (1 - 22.39%))
Current Ratio = 2.21 (Total Current Assets 231.5m / Total Current Liabilities 104.8m)
Debt / Equity = 0.52 (Debt 278.9m / totalStockholderEquity, last quarter 534.0m)
Debt / EBITDA = 1.64 (Net Debt 275.0m / EBITDA 167.7m)
Debt / FCF = 3.19 (Net Debt 275.0m / FCF TTM 86.1m)
Total Stockholder Equity = 511.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 9.21% (Net Income 81.5m / Total Assets 1.00b)
RoE = 15.95% (Net Income TTM 81.5m / Total Stockholder Equity 511.1m)
RoCE = 15.24% (EBIT 115.1m / Capital Employed (Equity 511.1m + L.T.Debt 244.0m))
RoIC = 9.97% (NOPAT 89.3m / Invested Capital 895.9m)
WACC = 7.38% (E(3.24b)/V(3.52b) * Re(7.69%) + D(278.9m)/V(3.52b) * Rd(4.84%) * (1-Tc(0.22)))
Discount Rate = 7.69% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -55.56 | Cagr: -0.08%
[DCF] Terminal Value 77.97% ; FCFF base≈79.7m ; Y1≈91.3m ; Y5≈134.4m
[DCF] Fair Price = 83.73 (EV 2.02b - Net Debt 275.0m = Equity 1.75b / Shares 20.9m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 84.29 | EPS CAGR: 9.85% | SUE: 0.24 | # QB: 0
Revenue Correlation: 89.20 | Revenue CAGR: 6.11% | SUE: 1.09 | # QB: 1
EPS current Quarter (2026-06-30): EPS=1.53 | Chg30d=+15.41% | Revisions=+20% | Analysts=2
EPS next Quarter (2026-09-30): EPS=1.36 | Chg30d=+14.23% | Revisions=+20% | Analysts=2
EPS current Year (2027-03-31): EPS=4.82 | Chg30d=+15.33% | Revisions=+20% | GrowthEPS=+21.8% | GrowthRev=+7.6%
EPS next Year (2028-03-31): EPS=5.39 | Chg30d=+14.79% | Revisions=+20% | GrowthEPS=+12.0% | GrowthRev=+5.4%
[Analyst] Revisions Ratio: +20%